Nanospectra Biosciences snags funding

Nanospectra Biosciences, Inc., a medical device company, has closed on an initial $3 million in Series B-1 financing.

Nanospectra Biosciences, Inc., a medical device company, has closed on an initial $3 million in Series B-1 financing. Sirtex Medical was the lead investor.

Source: Press Release